The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
9 pts

Opinion on  AspenBio Pharma Inc. (APPY)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
My UpDown Virtual Investing Portfolio

Jan 01, 2009 04:22 PM GMT
Mikerun
Return Risk
+1.04% LOW
Principal

My UpDown Virtual Investing Portfolio





Start earning real money with zero risk while improving your trading skills and strategies at the UpDown Virtual Investing website -- just click on the image above or any of the text links to the site in this article to sign up today. My stats and profile are featured in the accompanying table and on my blog site below the last posted entry. I started trading at the UpDown on 11/23/08 with a gain of 32.5% through today -- my profile name on the site is 'ETFinnovators' with a portfolio of long positions and links to my articles on the following stocks since the site does not currently allow users to view each others portfolios.

Altria (MO)

AMAG Pharma (AMAG)

Apple (AAPL)

AspenBio Pharma (APPY)

Celgene (CELG)

Cypress Bioscience (CYPB)

Momenta Pharma (MNTA)

UpDown is the ultimate risk/reward trade since it is free and easy to register and users can earn real money at the site in two ways. The first is by beating the market (S&P 500 Index) on a monthly basis and the second is by referring investors. However, the referral system is designed to encourage legitimate referrals by basing the payment on how much the referred person earns on the site. So, if you refer someone who earns $100, you will receive 10% or $10 as a referral bonus.

The UpDown is also a social networking site for investors, allowing users to form groups, post stock ideas, and collaborate with other investors. The UpDown allows users to trade frequently and closely resembles real-world trading conditions by placing restrictions on maximum positions based on average trading volume and no position may exceed 20% of a user's portfolio value.


APPY:  This call was made on 01/01/09 @ $6.17
Rating:   Positive   $6.17 (01/01/09)
Closed:   01/02/2009 @ $6.392 (+3.60% in 24 hours)


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +34.25% 381
2 18.14 +72.34% 210
3 17.66 +25.65% 55
4 13.47 +14.32% 62
5 12.13 +76.91% 39


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
AspenBio Pharma Inc. (APPY)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
81.5%
Top:
100.0%




Latest Picks by Mike Havrilla
Symbol SP Sentiment Rating Return Since
DNDN Positive -0.22% 11/28/09
UNIFF N/A Positive n/a 11/28/09
CLDA N/A Positive +3.76% 11/26/09
PBIO N/A Positive -9.25% 11/24/09
PUMD N/A Positive n/a 11/23/09

View All >
   
Mike Havrilla previously rated APPY
Positive -29.54% Extreme FDA Medical Device Trades: 7 Stocks Under $5
07/05/2009
9
Positive +29.51% Updated Clinical Trial and FDA Decision Calendars
03/15/2009
9
Positive -77.17% 20 Emerging Healthcare Stocks to Watch in '09
01/10/2009
9
Positive +0.00% Buyout Binge Begins for Bio-Pharma, Diagnostics
01/10/2009
9
Positive +0.75% Virtual Investing at UpDown and MarketGuru
01/02/2009
9
Positive +1.98% Four Healthy Stocks Trading Above Moving Averages
12/31/2008
9
Positive -0.82% Anticipating Active '09 for AspenBio Pharma
12/31/2008
9
Positive +5.35% Top Five Rated Preventive Medicine Stocks
12/29/2008
9
Positive -6.31% A New Emerging Diagnostics Index
12/26/2008
9
Positive +11.96% Five Healthcare Stocks for a Happy New Year
12/23/2008
9
Positive +10.40% Stock Picks for a 'Roadhouse Blues' Market
11/21/2008
9
Positive +2.04% Six Healthcare Stocks on Sale
10/24/2008
9
Positive +8.89% Market Notes: AspenBio Pharma + Microsoft-Yahoo!?
10/16/2008
9
Positive -27.54% An Overview of the Global Animal Care Industry
08/15/2008
3
Positive +2.64% AspenBio Pharma Executes On Its Plan for FDA Clearance of AppyScore
07/19/2008
3





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch